TGFB1 and glioblastoma: For example, by isolating quiescent GBM cells, bioinformatics analyses and functional assays showed that hypoxia and TGFβ signaling may drive the identity of quiescent GBM cells, providing a potential mechanism to ameliorate therapy resistance.60